Effect of aminoglutethimide on urinary steroid excretion in patients with congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency.
D015065:17-Hydroxycorticosteroids / Q000652:urine*; D015068:17-Ketosteroids / Q000652:urine*; D006907:17-alpha-Hydroxypregnenolone / Q000096:biosynthesis; D000311:Adrenal Glands / Q000201:enzymology; D000312:Adrenal Hyperplasia, Congenital / Q000188:drug therapy / Q000378:metabolism / Q000652:urine*; D000315:Adrenalectomy; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000328:Adult; D000616:Aminoglutethimide / Q000494:pharmacology / Q000627:therapeutic use; D000738:Androsterone / Q000652:urine; D000814:Aniline Compounds / Q000494:pharmacology*; D000927:Anticonvulsants / Q000494:pharmacology*; D002624:Chemistry, Clinical; D002986:Clinical Trials as Topic; D003687:Dehydroepiandrosterone / Q000652:urine; D003864:Depression, Chemical; D003907:Dexamethasone; D005043:Etiocholanolone / Q000652:urine; D005260:Female; D006801:Humans; D008661:Metabolism, Inborn Errors / Q000150:complications; D008797:Metyrapone; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors*; D011279:Pregnanetriol / Q000652:urine; D011728:Pyridones / Q000494:pharmacology*
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000814:Aniline Compounds; D000927:Anticonvulsants; D011728:Pyridones; D000616:Aminoglutethimide; D011279:Pregnanetriol; D006907:17-alpha-Hydroxypregnenolone; D003687:Dehydroepiandrosterone; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D005043:Etiocholanolone; D000738:Androsterone; D006899:Mixed Function Oxygenases; D008797:Metyrapone